Also Known As:

Drug Classification:

What are Antiplatelet Agents?

Antiplatelet Agents are Coagulation Modifiers that interfere with the coagulation process.

Coagulation is the process by which blood changes from a liquid to a gel, forming a blood clot. Naturally, blood clotting is an essential process that prevents excessive bleeding when a blood vessel is injured. Platelets (a type of blood cell) and proteins in the blood work together to stop the bleeding by forming a clot over the injury.

Antiplatelet treatment is used to prevent the formation of new blood clots. They are used in the prevention and treatment of Myocardial Infarction, Ischaemic Strokes, Pulmonary Embolisms, and other serious cardiovascular events.

Antiplatelet Agents interfere with the binding of platelets by impairing the enzymes or receptors required for platelet activation and aggregation.

The main types of Antiplatelet Agents are:
•   Glycoprotein Platelet Inhibitors
•   Platelet Aggregation Inhibitors
•   Protease-Activated Receptor-1 Antagonists